These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24236705)

  • 21. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 22. The changing relationship between patent owners and researchers.
    Holdreith JM; Kurtz JR
    Pharm Pat Anal; 2013 Mar; 2(2):173-6. PubMed ID: 24237022
    [No Abstract]   [Full Text] [Related]  

  • 23. Japan's novelty grace period solves the dilemma of 'publish and perish'.
    Tessensohn JA; Yamamoto S
    Nat Biotechnol; 2007 Jan; 25(1):55-7. PubMed ID: 17211396
    [No Abstract]   [Full Text] [Related]  

  • 24. When science rides the MTA.
    Dove A
    J Clin Invest; 2002 Aug; 110(4):425-7. PubMed ID: 12189233
    [No Abstract]   [Full Text] [Related]  

  • 25. Patent law. New rules for German professors.
    Kilger C; Bartenbach K
    Science; 2002 Nov; 298(5596):1173-5. PubMed ID: 12424355
    [No Abstract]   [Full Text] [Related]  

  • 26. Streamlining the transfer of research tools.
    Eisenberg RS
    Acad Med; 1999 Jun; 74(6):683-5. PubMed ID: 10386098
    [No Abstract]   [Full Text] [Related]  

  • 27. Japan lays out 55-point patent plan.
    Cyranoski D
    Nature; 2002 Jul; 418(6894):116. PubMed ID: 12110855
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of effective patents on future innovations in nanomedicine.
    Bosetti R; Vereeck L
    Pharm Pat Anal; 2012 Mar; 1(1):37-43. PubMed ID: 24236712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 30. Where have all the antibiotic patents gone?
    Katz ML; Mueller LV; Polyakov M; Weinstock SF
    Nat Biotechnol; 2006 Dec; 24(12):1529-31. PubMed ID: 17160057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The generic Research and Development possibilities after Hungary accessed th European Patent Convention].
    Kelen A; Angyal N; Máthé Z; Bódis A; Hódi K
    Acta Pharm Hung; 2003; 73(2):123-9. PubMed ID: 14702693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delaying generic competition--corporate payoffs and the future of Plavix.
    Shuchman M
    N Engl J Med; 2006 Sep; 355(13):1297-300. PubMed ID: 17005945
    [No Abstract]   [Full Text] [Related]  

  • 33. Bid to block Yellowstone enzymes deal.
    Macilwain C
    Nature; 1998 Mar; 392(6672):117. PubMed ID: 9515949
    [No Abstract]   [Full Text] [Related]  

  • 34. Innovation: The big idea of technology transfer.
    Schubert C
    Nature; 2012 Apr; 484(7393):277-8. PubMed ID: 22506281
    [No Abstract]   [Full Text] [Related]  

  • 35. Strategic options for brand-name prescription drugs when patents expire.
    Mehta SC; Mehta SS
    Health Mark Q; 1997; 14(3):107-14. PubMed ID: 10167309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Science and the law. Working through the patent problem.
    Walsh JP; Cohen WM; Arora A
    Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
    [No Abstract]   [Full Text] [Related]  

  • 37. Strategic patent licensing for public research organizations: deploying restriction and reservation clauses to promote medical R&D in developing countries.
    Evans GE
    Am J Law Med; 2008; 34(2-3):175-223. PubMed ID: 18697692
    [No Abstract]   [Full Text] [Related]  

  • 38. Biotechnology transfer at the National Institutes of Health.
    Chen PS
    Qual Assur; 1993 Dec; 2(4):345-52. PubMed ID: 7952969
    [No Abstract]   [Full Text] [Related]  

  • 39. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 40. Knowledge commons or economic engine--what's a university for?
    Williams-Jones B
    J Med Ethics; 2005 May; 31(5):249-50. PubMed ID: 15863677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.